Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Non-steroidal Anti-inflammatory Drugs (NSAID) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bayer

    • Elanco

    • Ecotrin

    • Zoetis

    • Boehringer Ingelheim

    • Generic

    • St Joseph

    • Merck Animal Health

    • Merial

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Salicylates

    • Propionic acid derivatives

    • Acetic acid derivatives

    • Enolic acid (Oxicam) derivatives

    • Anthranilic acid derivatives (Fenamates)

    • Selective COX-2 inhibitors (Coxibs)

    • Sulfonanilides

    Application:

    • Human

    • Animals

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Overview

      • 1.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Scope and Market Segments

      • 1.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Characteristics

      • 1.1.3 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Salicylates

      • 1.2.2 Propionic acid derivatives

      • 1.2.3 Acetic acid derivatives

      • 1.2.4 Enolic acid (Oxicam) derivatives

      • 1.2.5 Anthranilic acid derivatives (Fenamates)

      • 1.2.6 Selective COX-2 inhibitors (Coxibs)

      • 1.2.7 Sulfonanilides

    • 1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Human

      • 1.3.2 Animals

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry PEST Analysis

    • 2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Non-steroidal Anti-inflammatory Drugs (NSAID) Industry

    Chapter 3 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Manufacturer

    • 3.1 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Top 3 Players

    Chapter 4 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type (2017-2028)

    • 4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trend, by Type

    • 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trend, by Type (2017-2028)

    • 4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 7.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 7.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    • 7.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast, by Country

      • 7.3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    • 8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 9.1 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 9.2 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    • 9.3 APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast, by Country

      • 9.3.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 10.1 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 10.2 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    • 10.3 Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Company Profiles

      • 11.1 Bayer

        • 11.1.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Elanco

        • 11.2.1 Elanco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.2.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ecotrin

        • 11.3.1 Ecotrin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.3.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Zoetis

        • 11.4.1 Zoetis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.4.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Boehringer Ingelheim

        • 11.5.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.5.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Generic

        • 11.6.1 Generic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.6.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 St Joseph

        • 11.7.1 St Joseph Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.7.3 St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Merck Animal Health

        • 11.8.1 Merck Animal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.8.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Merial

        • 11.9.1 Merial Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Profiles, Application and Specification

        • 11.9.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Investment Prospect and Risk Assessment

    • 12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value and Growth Rate (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value and Growth Rate (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Salicylates (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Propionic acid derivatives (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Acetic acid derivatives (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Enolic acid (Oxicam) derivatives (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Anthranilic acid derivatives (Fenamates) (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Selective COX-2 inhibitors (Coxibs) (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Sulfonanilides (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Human (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Animals (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share, by Manufacturer in 2021

    • Figure Global and China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share, by Manufacturer in 2022

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Type (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trend, by Type (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Type (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Type (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trend, by Type (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Application (2017-2028)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Application (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value, by Application (2017-2028)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Application (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share, by Application (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Import, Consumption and Export (2017-2022)

    • Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure UK Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure France Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure France Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Table APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value and Growth Rate (2017-2028)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Elanco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Elanco Product Profiles, Application and Specification

    • Table Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ecotrin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ecotrin Product Profiles, Application and Specification

    • Table Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zoetis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zoetis Product Profiles, Application and Specification

    • Table Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Generic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Generic Product Profiles, Application and Specification

    • Table Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table St Joseph Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table St Joseph Product Profiles, Application and Specification

    • Table St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Animal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Animal Health Product Profiles, Application and Specification

    • Table Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merial Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merial Product Profiles, Application and Specification

    • Table Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.